WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001082903) ENTERIC COATED FORMULATION OF BISPHOSPHONIC ACID COMPOUNDS AND ASSOCIATED THERAPEUTIC METHODS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/082903    International Application No.:    PCT/US2001/013577
Publication Date: 08.11.2001 International Filing Date: 27.04.2001
Chapter 2 Demand Filed:    27.11.2001    
IPC:
A61K 9/48 (2006.01), A61K 31/663 (2006.01)
Applicants: LIPOCINE, INC. [US/US]; 800 North 350 West, Suite 314 Salt Lake City, UT 84103 (US)
Inventors: CHEN, Feng-Jing; (US).
PATEL, Mahesh, V.; (US)
Agent: REED, Dianne, E.; Reed & Associates 800 Menlo Avenue, Suite 210 Menlo Park, CA 04025 (US)
Priority Data:
09/561,489 28.04.2000 US
Title (EN) ENTERIC COATED FORMULATION OF BISPHOSPHONIC ACID COMPOUNDS AND ASSOCIATED THERAPEUTIC METHODS
(FR) PREPARATION GASTRO-RESISTANTE DE COMPOSES D'ACIDE BISPHOSPHONIQUE ET METHODES THERAPEUTIQUES ASSOCIEES
Abstract: front page image
(EN)Oral dosage forms are provided for the administration of a bisphosphonic acid compound in the prevention and treatment of conditions involving calcium or phosphate metabolism, i.e., conditions associated with bone resorption such as osteoporosis, Paget's disease, periprosthetic bone loss, osteolysis, malignant hypercalcemia, metastatic bone disease, multiple myeloma, and periodontal disease. The dosage forms are either enterically coated capsules housing the drug in a liquid or semi-solid carrier, or enterically coated osmotically activated drug delivery devices.
(FR)L'invention concerne des formes galéniques orales destinées à l'administration d'un composé d'acide bisphosphonique dans le cadre de la prévention et du traitement d'états mettant en cause le métabolisme du calcium et du phosphate, c'est-à-dire des états associés à la résorption osseuse, telle que l'ostéoporose, la maladie osseuse de Paget, la perte osseuse périprothétique, l'ostéolyse, l'hypercalcémie maligne, la maladie osseuse métastatique, le myélome multiple et la parodontopathie. Les formes galéniques se présentent sous la forme de capsules gastro-résistantes renfermant le médicament dans un support liquide ou semi-solide ou de dispositifs d'administration de médicaments à activation osmotique gastro-résistants.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)